Product Details for: Erbitux

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/50ML (2MG/ML)
Single-Dose Vial
351(a)
Erbitux
Rx
002
Injection
Intravenous
200MG/100ML (2MG/ML)
Single-Dose Vial
351(a)
Erbitux
Rx
Proper Name
cetuximab
BLA Number
125084
Applicant
ImClone LLC a wholly-owned subsidiary of Eli Lilly and Company
Original Approval Date
February 12, 2004
Date of First Licensure
RETURN TO SEARCH RESULTS